Combination of secukinumab and natalizumab in the treatment of a patient with psoriatic arthritis and multiple sclerosis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Combination of secukinumab and natalizumab in the treatment of a patient with psoriatic arthritis and multiple sclerosis ; volume:82 ; number:S 01 ; year:2024 ; 01
Konferenz: 25th BCTRIMS Annual Meeting; 2024-06-05; Tivoli Mofarrej São Paulo - SP
Arquivos de neuro-psiquiatria ; 82, Heft S 01 (2024), 01
- Contributor
-
Gerhardt, Marciéli
Bonato, Giuseppe Dick
Passos, Giordani Rodrigues dos
Becker, Jefferson
- DOI
-
10.1055/s-0044-1789394
- URN
-
urn:nbn:de:101:1-2412121005507.145124465699
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gerhardt, Marciéli
- Bonato, Giuseppe Dick
- Passos, Giordani Rodrigues dos
- Becker, Jefferson
Other Objects (12)
Secukinumab: A Review in Psoriatic Arthritis
Secukinumab: A New Treatment Option for Psoriatic Arthritis
Correction to: Secukinumab: A Review in Psoriatic Arthritis
Erratum to: Secukinumab: A New Treatment Option for Psoriatic Arthritis
A Review of the Use of Secukinumab for Psoriatic Arthritis
Natalizumab May Improve Cognition and Mood in Multiple Sclerosis
Cost Effectiveness of Secukinumab for the Treatment of Active Psoriatic Arthritis in the UK
Risk perception in natalizumab-treated multiple sclerosis patients and their neurologists
Bruising following natalizumab infusion for relapsing-remitting multiple sclerosis: a case report
Bilateral acute retinal necrosis in a patient with multiple sclerosis on natalizumab
Multiple sclerosis disease activity and disability following discontinuation of natalizumab for pregnancy
Vitiligo with Progressive Repigmentation during Secukinumab Treatment in a Patient with Psoriatic Arthritis: A Case Report
Secukinumab: A Review in Psoriatic Arthritis
Secukinumab: A New Treatment Option for Psoriatic Arthritis
Correction to: Secukinumab: A Review in Psoriatic Arthritis
Erratum to: Secukinumab: A New Treatment Option for Psoriatic Arthritis
A Review of the Use of Secukinumab for Psoriatic Arthritis
Natalizumab May Improve Cognition and Mood in Multiple Sclerosis
Cost Effectiveness of Secukinumab for the Treatment of Active Psoriatic Arthritis in the UK
Risk perception in natalizumab-treated multiple sclerosis patients and their neurologists
Bruising following natalizumab infusion for relapsing-remitting multiple sclerosis: a case report
Bilateral acute retinal necrosis in a patient with multiple sclerosis on natalizumab
Multiple sclerosis disease activity and disability following discontinuation of natalizumab for pregnancy
Vitiligo with Progressive Repigmentation during Secukinumab Treatment in a Patient with Psoriatic Arthritis: A Case Report
Secukinumab: A Review in Psoriatic Arthritis
Secukinumab: A New Treatment Option for Psoriatic Arthritis
Correction to: Secukinumab: A Review in Psoriatic Arthritis
Erratum to: Secukinumab: A New Treatment Option for Psoriatic Arthritis
A Review of the Use of Secukinumab for Psoriatic Arthritis
Natalizumab May Improve Cognition and Mood in Multiple Sclerosis
Cost Effectiveness of Secukinumab for the Treatment of Active Psoriatic Arthritis in the UK
Risk perception in natalizumab-treated multiple sclerosis patients and their neurologists
Bruising following natalizumab infusion for relapsing-remitting multiple sclerosis: a case report
Bilateral acute retinal necrosis in a patient with multiple sclerosis on natalizumab
Multiple sclerosis disease activity and disability following discontinuation of natalizumab for pregnancy